Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Slides:

Advertisements

Similar presentations

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Advertisements

Time to pregnancy after a previous miscarriage in subfertile couples

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the.

Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice Lysanne.

Couples dropping out of a reimbursed intrauterine insemination program: what is their prognostic profile and why do they drop out? Inge M. Custers, M.D.,

Effectiveness of intrauterine insemination in subfertile couples with an isolated cervical factor: a randomized clinical trial Pieternel Steures, M.D.,

Inge M. Custers, M. D. , Pieternel Steures, M. D

Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis Ouijdane Hamdine,

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome Anuja Dokras, M.D., Ph.D., Shailly Saini,

Esther Leushuis, M. D. , Jan Willem van der Steeg, Ph. D. , M. D

Role of semen analysis in subfertile couples

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis Héctor F. Escobar-Morreale, M.D., Ph.D., Manuel Luque-Ramírez,

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome

Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women Babak Mokhlesi, M.D.,

Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D

Michael M. Alper, M.D. Fertility and Sterility

Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M

Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group Bart C.J.M.

Femi Janse, M. D. , Larissa M. de With, M. D. , Karen J. Duran, Ph. D

Esther Leushuis, M. D. , Jan Willem van der Steeg, M. D

Patient-tailored ovarian stimulation for in vitro fertilization

Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome Anuja Dokras, M.D., Ph.D., Shailly Saini,

Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome

"Patient-centered fertility treatment": what is required?

Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome Shirei Ohgi, M.D., Koji Nakagawa, M.D., Ph.D., Rieko Kojima,

Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study Angela Kerchner, B.A., Whitney Lester,

Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F

Trends in clinical reproductive medicine research: 10 years of growth

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Evolutionary determinants of polycystic ovary syndrome: part 1

Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized.

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the.

Chao-Chin Hsu, M. D. , Ph. D. , Hsin-Chih Kuo, Ph. D

Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens

Andrew C. Bjonnes, M.S., Richa Saxena, Ph.D., Corrine K. Welt, M.D.

Inge M. Custers, M. D. , Pieternel Steures, M. D

Serum luteinizing hormone levels are markedly increased and significantly correlated with Δ4-androstenedione levels in lean women with polycystic ovary.

Hyperglycemia Stimulates Activation of Nuclear Factor κB (NFκB) in Mononuclear Cells (MNC) of Women With Polycystic Ovary Syndrome (PCOS) F. Gonzalez,

Tomer Singer, M. D. , David H. Barad, M. D. , M. S

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision- analytic model Lobke M. Moolenaar, M.D., Frank J.M. Broekmans,

Time to pregnancy after a previous miscarriage in subfertile couples

Increased secretion of amylin in women with polycystic ovary syndrome

Eva Balkenende, Taghride Dahhan, M. D. , Fulco van der Veen, M. D, Ph

Fertile lifespan characteristics and all-cause and cause-specific mortality among postmenopausal women: the Rotterdam Study Loes Jaspers, M.D., Maryam.

The additional value of ovarian hyperstimulation in intrauterine insemination for couples with an abnormal postcoital test and a poor prognosis: a randomized.

Fleur R. Cattrall, M. B. B. S. , Beverley J. Vollenhoven, M. B. B. S

Antoni J. Duleba, M.D., Ibrahim M. Ahmed, M.D. Fertility and Sterility

Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment Richard Fleming, Ph.D.,

Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial Antoni J. Duleba, M.D.,

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Paolo Moghetti, M.D. Fertility and Sterility

Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify.

Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome Yuwen Wu, M.D., Jianhua Zhang,

Current evaluation of amenorrhea

Inappropriate gonadotropin secretion in polycystic ovary syndrome

Tsan-Hon Liou, M. D. , Ph. D. , Jen-Hung Yang, M. D. , Ph. D

High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model.

In vitro sildenafil citrate use as a sperm motility stimulant

Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility Joop S.E Laven, Ph.D., Annemarie G.M.G.J.

Effectiveness of human menopausal gonadotropin versus recombinant follicle- stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive.

Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients Artemis Karkanaki,

Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Nadine M.P. Daan, M.D., Yvonne V.

Early menopause in mothers of children with Down syndrome?

Increased risk of depressive disorders in women with polycystic ovary syndrome Elizabeth Hollinrake, B.S., Alison Abreu, M.D., Michelle Maifeld, R.N.C.,

Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome Kevin H. Maas, M.D., Ph.D., Sandy Chuan,

Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels

Presentation transcript:

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D., Bart C.J.M. Fauser, M.D., Ph.D., Joop S.E. Laven, MD, Ph.D., Marinus J. Eijkemans, Ph.D., Fulco van der Veen, M.D., Ph.D. Fertility and Sterility Volume 86, Issue 6, Pages 1710-1715 (December 2006) DOI: 10.1016/j.fertnstert.2006.05.046 Copyright © 2006 American Society for Reproductive Medicine Terms and Conditions

FIGURE 1 Calibration (spline) curve with confidence intervals for the regression line. van Wely. Validation of FSH response model in PCOS. Fertil Steril 2006. Fertility and Sterility 2006 86, 1710-1715DOI: (10.1016/j.fertnstert.2006.05.046) Copyright © 2006 American Society for Reproductive Medicine Terms and Conditions